Gian Maria Busetto - Concepedia

Author

Gian Maria Busetto

Also Known As

Di Pierro, G BUSETTO, G M Busetto, G. Busetto, G. M. Busetto, G.M. Busetto, Gian Busetto, Gian M. BUSETTO, Gian Maria BUSETTO, Gian Maria Busetto

343

Publications

6.3K

Citations

H-Index

Concepts

All Affiliations

Sapienza University of Rome European Institute of Oncology Policlinico Umberto I University of Foggia University of Bari Aldo Moro

About

Gian Maria Busetto is an author at Sapienza University of Rome specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	25	1.2K
2	Public Health	5	5	259
3	Health Sciences	2	2	141
4	Engineering	1	1	17
5	Biostatistics	1	1	32

Gian Maria Busetto

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Effect of metabolic and antioxidant supplementation on sperm parameters in oligo-astheno-teratozoospermia, with and without varicocele: A double-blind placebo-controlled study Gian Maria Busetto, Ashok Agarwal, Ashraf Virmani, Andrologia NutritionFertilityReproductive HealthTotal MotilityGynecology	2018	111
Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer: a CellSearch analysis Paola Gazzaniga, Angela Gradilone, Ettore De Berardinis, Annals of Oncology Tumor BiologyUrologyGenitourinary CancerCancer DetectionMedicine	2012	108
Circulating tumor cells detection has independent prognostic impact in high-risk non-muscle invasive bladder cancer Paola Gazzaniga, Ettore De Berardinis, Cristina Raimondi, International Journal of Cancer Ctc AnalysesTumor BiologyPrognostic BiomarkersUrologySurgical Oncology	2014	107
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer Matteo Ferro, Mihai Dorin Vartolomei, Giorgio Ivan Russo, World Journal of Urology UrologyCancer ImmunosurveillanceGenitourinary CancerMedicineBody Mass Index	2018	96
Double‐blind, randomised, placebo‐controlled trial on the effect of L‐carnitine and L‐acetylcarnitine on sperm parameters in men with idiopathic oligoasthenozoospermia S. Mičić, Nataša Lalić, Dejan Djordjević, Andrologia	2019	95
Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer Francesco Cantiello, Giorgio Ivan Russo, Mihai Dorin Vartolomei, European Urology Oncology Prognostic BiomarkersUrologyUrologic Cancer EpidemiologySystemic Inflammatory MarkersGenitourinary Cancer	2018	86
Neutrophil percentage-to-albumin Ratio Predicts Mortality in Bladder Cancer Patients Treated With Neoadjuvant Chemotherapy Followed By Radical Cystectomy Matteo Ferro, Dragoș-Florin Babă, Ottavio De Cobelli, Future Science OA	2021	69
Minimally invasive infrapubic inflatable penile prosthesis implant for erectile dysfunction: evaluation of efficacy, satisfaction profile and complications Gabriele Antonini, Gian Maria Busetto, Ettore De Berardinis, International Journal of Impotence Research	2015	68
Preoperative detection of Vesical Imaging‐Reporting and Data System (VI‐RADS) score 5 reliably identifies extravesical extension of urothelial carcinoma of the urinary bladder and predicts significant delayed time to cystectomy: time to reconsider the need for primary deep transurethral resection of bladder tumour in cases of locally advanced disease? Francesco Del Giudice, Costantino Leonardo, Giuseppe Simone, British Journal of Urology	2020	68
Modified Glasgow Prognostic Score is Associated With Risk of Recurrence in Bladder Cancer Patients After Radical Cystectomy Matteo Ferro, Ottavio De Cobelli, Carlo Buonerba, Medicine	2015	63

Page 1